严重急性呼吸系统综合征冠状病毒2型:关注结构、诊断和疫苗开发的文献综述

Q3 Engineering
Mohammed Hamzah Abdulkadhim Al-Saadi, W. H. Hoidy
{"title":"严重急性呼吸系统综合征冠状病毒2型:关注结构、诊断和疫苗开发的文献综述","authors":"Mohammed Hamzah Abdulkadhim Al-Saadi, W. H. Hoidy","doi":"10.5101/nbe.v14i4.p343-348","DOIUrl":null,"url":null,"abstract":"SARS-CoV-2 is a highly pathogenic novel ongoing-pandemic virus. It causes COVID-19. Little is known about SARS-CoV-2 biology, countermeasure, and its origin. SARS-CoV-2 is characterized by high infectiousness and sever pathogenesis. COVID-19 crosses the bounders of all continents in a high spreading manner. Here, several aspects regarding the origin and the molecular structure of this novel virus as well as the production of effective vaccines have been addressed. This article illustrated that SARS-CoV-2 was not being recombined inside laboratory and it has a complicated genome that led to sophisticated pathogenesis. Additionally, an important structural protein known as spike S was demonstrated by researchers as an important protein used by the virus for host cell entry as well as for vaccine development. However, the efforts for viral diagnosis and genomic demonstration as well as vaccine production are promising to tackle COVID-19. These perspectives will help in COVID-19 control. However, further investigations are urgently needed to figure out which controlling tactic is more efficient not only in the case of SARS-CoV-2 but also for future pandemics.Copyright © Mohammed Hamzah Abdulkadhim Al-Saadi and Wisam Hindawi Hoidy.","PeriodicalId":18971,"journal":{"name":"Nano Biomedicine and Engineering","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"SARS-CoV-2: Literature Review Focusing on Structure, Diagnosis and Vaccine Development\",\"authors\":\"Mohammed Hamzah Abdulkadhim Al-Saadi, W. H. Hoidy\",\"doi\":\"10.5101/nbe.v14i4.p343-348\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"SARS-CoV-2 is a highly pathogenic novel ongoing-pandemic virus. It causes COVID-19. Little is known about SARS-CoV-2 biology, countermeasure, and its origin. SARS-CoV-2 is characterized by high infectiousness and sever pathogenesis. COVID-19 crosses the bounders of all continents in a high spreading manner. Here, several aspects regarding the origin and the molecular structure of this novel virus as well as the production of effective vaccines have been addressed. This article illustrated that SARS-CoV-2 was not being recombined inside laboratory and it has a complicated genome that led to sophisticated pathogenesis. Additionally, an important structural protein known as spike S was demonstrated by researchers as an important protein used by the virus for host cell entry as well as for vaccine development. However, the efforts for viral diagnosis and genomic demonstration as well as vaccine production are promising to tackle COVID-19. These perspectives will help in COVID-19 control. However, further investigations are urgently needed to figure out which controlling tactic is more efficient not only in the case of SARS-CoV-2 but also for future pandemics.Copyright © Mohammed Hamzah Abdulkadhim Al-Saadi and Wisam Hindawi Hoidy.\",\"PeriodicalId\":18971,\"journal\":{\"name\":\"Nano Biomedicine and Engineering\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nano Biomedicine and Engineering\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5101/nbe.v14i4.p343-348\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Engineering\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nano Biomedicine and Engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5101/nbe.v14i4.p343-348","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 0

摘要

严重急性呼吸系统综合征冠状病毒2型是一种高致病性的新型流行性病毒。它导致新冠肺炎。对严重急性呼吸系统综合征冠状病毒2型的生物学、对策及其起源知之甚少。严重急性呼吸系统综合征冠状病毒2型具有高传染性和严重的发病机制。新冠肺炎以高度传播的方式跨越各大洲。在这里,已经讨论了关于这种新型病毒的起源和分子结构以及有效疫苗的生产的几个方面。这篇文章表明,严重急性呼吸系统综合征冠状病毒2型并没有在实验室内重组,它有一个复杂的基因组,导致了复杂的发病机制。此外,一种被称为刺突S的重要结构蛋白被研究人员证明是病毒用于宿主细胞进入和疫苗开发的重要蛋白。然而,病毒诊断和基因组证明以及疫苗生产的努力有望应对新冠肺炎。这些观点将有助于控制新冠肺炎。然而,迫切需要进一步的调查,以找出哪种控制策略不仅在严重急性呼吸系统综合征冠状病毒2型的情况下更有效,而且在未来的流行病中也更有效。版权所有©Mohammed Hamzah Abdulkadhim Al Saadi和Wisam Hindawi Hoidy。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
SARS-CoV-2: Literature Review Focusing on Structure, Diagnosis and Vaccine Development
SARS-CoV-2 is a highly pathogenic novel ongoing-pandemic virus. It causes COVID-19. Little is known about SARS-CoV-2 biology, countermeasure, and its origin. SARS-CoV-2 is characterized by high infectiousness and sever pathogenesis. COVID-19 crosses the bounders of all continents in a high spreading manner. Here, several aspects regarding the origin and the molecular structure of this novel virus as well as the production of effective vaccines have been addressed. This article illustrated that SARS-CoV-2 was not being recombined inside laboratory and it has a complicated genome that led to sophisticated pathogenesis. Additionally, an important structural protein known as spike S was demonstrated by researchers as an important protein used by the virus for host cell entry as well as for vaccine development. However, the efforts for viral diagnosis and genomic demonstration as well as vaccine production are promising to tackle COVID-19. These perspectives will help in COVID-19 control. However, further investigations are urgently needed to figure out which controlling tactic is more efficient not only in the case of SARS-CoV-2 but also for future pandemics.Copyright © Mohammed Hamzah Abdulkadhim Al-Saadi and Wisam Hindawi Hoidy.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Nano Biomedicine and Engineering
Nano Biomedicine and Engineering Engineering-Biomedical Engineering
CiteScore
3.00
自引率
0.00%
发文量
9
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信